|
|
|
|
|
by yakak
1491 days ago
|
|
If I've been following this story correctly: FDA catches conspiracy to recklessly endanger (as in quite possibly murder) a huge number of infants over a vast geographic area. Perpetrators caught then not given sufficient help bypassing FDA procedures nor a reduction in oversight as they resume production and filling out paperwork they previously falsified. Other competitors apparently non-existent probably thanks to free market forces and this competitor who used illegal methods to have lower costs than legal operation. I.e. bad batch costs saved by falsifying paperwork. FDA hesitant to allow import of these products as foreign production would be out of its jurisdiction and the lowest international bidder is presumably saving more money than the factory they just closed, somehow.. Can the FDA single out specific EU countries and criticize their regulators or would it face massive pressure to approve all countries the US has a cozy relationship with that have an infant formula? I.e. the UK which has no regulatory history relevant to it's current restructuring as a non-EU Nation. Should thousands of US infants be among the first to iron out defects in a changing system for regulating potentially deadly products that is focused on being more cost effective for the UK? |
|
The article goes into the reasons for market consolidation. To summarize: there's a combination of steep regulatory barriers (which inherently favor big, established businesses with large lobbying and compliance budgets), single-supplier state purchase contracts that account for roughly half of all baby formula purchases, and effectively cutting off imports. The market forces are downstream of government action, and the market in question is anything but free.